CSS
PLXP

Cubist Systematic Strategies’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Cubist Systematic Strategies’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,270
Closed -$50K – 4695
2022
Q1 		$50K Sell
12,270
-53,340
-81% -$292K ﹤0.01% 3382
2021
Q4 		$526K Buy
65,610
+26,698
+69% +$313K 0.01% 2416
2021
Q3 		$751K Buy
+38,912
New +$680K 0.01% 1739
2021
Q2 		– Sell
-19,233
Closed -$174K – 3175
2021
Q1 		$174K Buy
+19,233
New +$141K ﹤0.01% 2522

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Cubist Systematic Strategies's PLXP Position: Q2 2022 in Review

Cubist Systematic Strategies sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2022, closing a stake of 12,270 shares — an estimated $50K sold.

Cubist Systematic Strategies first reported a position in PLXP in Q1 2021 and held it in 4 quarters. The position peaked at $751K in Q3 2021. 48 funds tracked by Wall St. Rank hold PLXP as of Q2 2022.

  • Cubist Systematic Strategies reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 12,270 PLx Pharma Inc. Common Stock shares in Q2 2022, an estimated $50K.
  • Cubist Systematic Strategies first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Cubist Systematic Strategies's PLx Pharma Inc. Common Stock position peaked at $751K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2022.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.